History
In 1938, German chemist Martin Lewinberg, founded Liomont Laboratories with a clear mission: “To develop, manufacture and market medicine to help relieve human pain.” In over 80 years, the company has continued to grow, both inside and out of Mexico, becoming a key element of the pharmaceutical industry, which will oversee the final process of the vaccine for COVID-19.
DATA
0
jobs
0
production plants
0
Patents Granted or in Process
Investment of
0
pesos
0
Countries where they export
